KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) FCF Payout Ratio (2016 - 2025)

Historic FCF Payout Ratio for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to 0.21.

  • Bristol Myers Squibb's FCF Payout Ratio fell 868.68% to 0.21 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.33, marking a year-over-year decrease of 611.66%. This contributed to the annual value of 0.35 for FY2024, which is 698.36% down from last year.
  • According to the latest figures from Q3 2025, Bristol Myers Squibb's FCF Payout Ratio is 0.21, which was down 868.68% from 0.35 recorded in Q2 2025.
  • Bristol Myers Squibb's FCF Payout Ratio's 5-year high stood at 0.74 during Q1 2025, with a 5-year trough of 0.0 in Q2 2021.
  • For the 5-year period, Bristol Myers Squibb's FCF Payout Ratio averaged around 0.34, with its median value being 0.3 (2021).
  • Per our database at Business Quant, Bristol Myers Squibb's FCF Payout Ratio tumbled by 9880.08% in 2021 and then surged by 1208690.11% in 2023.
  • Bristol Myers Squibb's FCF Payout Ratio (Quarter) stood at 0.29 in 2021, then soared by 31.53% to 0.39 in 2022, then decreased by 23.54% to 0.3 in 2023, then increased by 1.41% to 0.3 in 2024, then fell by 29.71% to 0.21 in 2025.
  • Its last three reported values are 0.21 in Q3 2025, 0.35 for Q2 2025, and 0.74 during Q1 2025.